India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

argenx advances clinical development of ARGX-119 in congenital myasthenic syndromes

Join Pharma | Login

	Editorial


	STILL A TOOTHLESS TIGER
	Tuesday, July 1, 2025
	Unethical marketing practices by the pharmaceutical companies have been a major issue the country has been facing for a long time now.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	argenx advances clinical development of ARGX-119 in congenital myasthenic syndromes
17:15 [IST]	Lupin forms LupinLife Consumer Healthcare with focus on OTC consumer wellness solutions
17:00 [IST]	Faron-supported research in Theranostics identifies sClever-1 as an independent driver of immune evasion in cancer, deepening the understanding of bexmarilimab’s mode of action
16:00 [IST]	Tyra Biosciences begins patient dosing in phase 2 study of TYRA-300 in low-grade intermediate risk non-muscle invasive bladder cancer
15:00 [IST]	Klotho Neurosciences moves forward with manufacturing gene therapy to treat amyotrophic lateral sclerosis
14:00 [IST]	China NMPA approves Hutchmed’s Orpathys in combo with Tagrisso to treat lung cancer patients with MET amplification after progression on first-line EGFR inhibitor therapy

more news >>

TOP NEWS


08:00 [IST]	DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity
08:00 [IST]	Indian pharma firms invited to supply medicines to Venezuela's Ministry of Education
08:00 [IST]	Explore new avenues for drug discovery, targeting novel bacterial pathways & mechanisms: Dr Atul Gogia
08:00 [IST]	A N Mohan re-elected president, Antony Tharyan, general secretary as AKCDA tackles expiry settlement debate
08:00 [IST]	India’s medical expertise in robotic surgeries draws patients from across the world
08:00 [IST]	DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Tango Therapeutics begins patient dosing in phase 1/2 trial of TNG462 plus Revolution Medicines’ daraxonrasib or zoldonrasib to treat RAS-mutant MTAP-deleted pancreatic or lung cancer
17:30 [IST]	Aldeyra Therapeutics gets US FDA’s special protocol assessment agreement letter for its drug candidate, ADX-2191 to treat primary vitreoretinal lymphoma
17:00 [IST]	Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product
16:00 [IST]	Bone Biologics seeks US patent for bone regeneration technology
12:15 [IST]	Biocon Biologics expands insulin access in Malaysia over 100 mn cartridges of rh-insulin supplied to Health Ministry; 345,000+ patients served
11:30 [IST]	Torrent Pharma to acquire controlling stake in JB Chemicals & Pharmaceuticals

more news >>

INTERVIEW


Telangana State’s pharma future hinges on strategic collaboration between industry, academia & government: KV Rambabu
KV Rambabu, president of Telangana State board of Indian Drug Manufacturers Association

Past Interviews...

	What's New?

AI minimises risks associated with med documentation Technology disrupts Indian lab equipment landscape Healthcare landscape undergoing dramatic shift PharmaTech Expo to drive growth and competitiveness Formulations industry going from strength to strength

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers